4-[3-(Ethoxymethoxy)thioxanthen-9-ylidene]-1-methylpiperidine;hydrochloride

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻喃类
• 英文名称: 4-[3-(Ethoxymethoxy)thioxanthen-9-ylidene]-1-methylpiperidine;hydrochloride
• 英文别名: 4-[3-(ethoxymethoxy)thioxanthen-9-ylidene]-1-methylpiperidine;hydrochloride
• 化学式: C22H26ClNO2S
• 分子量: 404.0
• InChiKey: AEPHPTVZHSQDSF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.47
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  47
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• [EN] SALT POLYMORPH OF THIOXANTHENE-9-YLIDENE-1-METHYL PIPERIDINE ACID ADDITION SALTS AS ANTIMIGRAINE COMPOUNDS<br/>[FR] FORMES POLYMORPHES DE SELS D'ADDITION D'ACIDE DE THIOXANTHÈNE-9-YLIDÈNE-1-MÉTHYLPIPÉRIDINES UTILISÉS COMME COMPOSÉS ANTIMIGRAINEUX
  申请人：BIOFRONTERA BIOSCIENCE GMBH

  公开号：WO2014118307A1

  公开（公告）日：2014-08-07

  The present invention relates to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidcne)-1-methyl piperidine salts and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine salts; especially to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride as well as to the use of these salts for preventing or treating migraine or pulmonary hypertension.

  本发明涉及4-(6-乙氧基-1-甲氧基-噻吩并[9]芳-1-亚甲基)-1-甲基哌啶盐和4-(6-乙氧基-1-羟基-噻吩并[9]芳-1-亚甲基)-1-甲基哌啶盐的新晶型；特别是4-(6-乙氧基-1-甲氧基-噻吩并[9]芳-1-亚甲基)-1-甲基哌啶盐酸盐和4-(6-乙氧基-1-羟基-噻吩并[9]芳-1-亚甲基)-1-甲基哌啶盐酸盐的新晶型，以及利用这些盐预防或治疗偏头痛或肺动脉高压。
• SALT POLYMORPH OF THIOXANTHENE-9-YLIDENE-1-METHYL PIPERIDINE ACID ADDITION SALTS AS ANTIMIGRAINE COMPOUNDS
  申请人：Biofrontera Bioscience GmbH

  公开号：EP2986606A1

  公开（公告）日：2016-02-24
• [EN] SALT POLYMORPH OF THIOXANTHENE - 9 - YLIDENE - 1 - METHYL PIPERIDINE ACID ADDITION SALTS AS ANTIMIGRAINE COMPOUNDS<br/>[FR] FORMES POLYMORPHES DE SELS D'ADDITION D'ACIDE DE THIOXANTHÈNE-9-YLIDÈNE-1-MÉTHYLPIPÉRIDINES UTILISÉS COMME COMPOSÉS ANTIMIGRAINEUX
  申请人：BIOFRONTERA BIOSCIENCE GMBH

  公开号：WO2014117863A1

  公开（公告）日：2014-08-07

  The present invention relates to novel crystal forms of 4-(6-ethoxy-l-methoxy-thioxanthene-9- ylidene)-1-methyl piperidine salts and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine salts; especially to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9- ylidene)-1-methyl piperidine hydrochloride and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)- 1-methyl piperidine hydrochloride as well as to the use of these salts for preventing or treating migraine or pulmonary hypertension.